NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Spruce Biosciences Inc (NASDAQ: SPRB)

 
SPRB Technical Analysis
2
As on 9th Jun 2023 SPRB STOCK Price closed @ 2.31 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.98 & Strong Sell for SHORT-TERM with Stoploss of 2.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SPRBSTOCK Price

Open 2.32 Change Price %
High 2.41 1 Day -0.02 -0.86
Low 2.28 1 Week -0.12 -4.94
Close 2.31 1 Month 0.25 12.14
Volume 83611 1 Year -2.72 -54.08
52 Week High 5.03 | 52 Week Low 0.99
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
SPRB
Daily Charts
SPRB
Intraday Charts
Whats New @
Bazaartrend
SPRB
Free Analysis
 
SPRB Important Levels Intraday
RESISTANCE2.56
RESISTANCE2.48
RESISTANCE2.43
RESISTANCE2.38
SUPPORT2.24
SUPPORT2.19
SUPPORT2.14
SUPPORT2.06
 
SPRB Forecast April 2024
4th UP Forecast6.41
3rd UP Forecast5.1
2nd UP Forecast4.28
1st UP Forecast3.47
1st DOWN Forecast1.15
2nd DOWN Forecast0.34
3rd DOWN Forecast-0.48
4th DOWN Forecast-1.79
 
SPRB Weekly Forecast
4th UP Forecast6.32
3rd UP Forecast5.03
2nd UP Forecast4.24
1st UP Forecast3.44
1st DOWN Forecast1.18
2nd DOWN Forecast0.38
3rd DOWN Forecast-0.41
4th DOWN Forecast-1.70
 
SPRB Forecast2024
4th UP Forecast10.67
3rd UP Forecast7.99
2nd UP Forecast6.33
1st UP Forecast4.68
1st DOWN Forecast-0.06
2nd DOWN Forecast-1.71
3rd DOWN Forecast-3.37
4th DOWN Forecast-6.05
 
 
SPRB Other Details
Segment EQ
Market Capital 113380872.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SPRB Address
SPRB
 
SPRB Latest News
 
Your Comments and Response on Spruce Biosciences Inc
 
SPRB Business Profile
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH). It offers tildacerfont, which is in Phase II clinical trial for children with classic CAH; and for females with polycystic ovary syndrome. In addition, it is involved in developing CAHmelia-203 which is in Phase 2b clinical trial for adult patients with classic CAH with poor disease control; and CAHmelia-204, which is in second Phase 2b clinical trial in adult patients with classic CAH with good disease control. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California. Address: 2001 Junipero Serra Boulevard, Daly City, CA, United States, 94014
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service